Indian Doctor’s Rabies Treatment That Might Reduce Cost by 100 Times Approved By WHO

The Logical Indian Crew Himachal Pradesh

February 9th, 2018 / 10:16 AM

Courtesy: The News Minute Image Credit: The Dog Place

In a major breakthrough in the medical field, a new treatment for rabies parasite has been recommended by the World Health Organisation (WHO) which could reduce the cost of treatment by almost 100 times.

Last week, WHO acknowledged the low-cost rabies treatment developed by Omesh Kumar Bharti, a field epidemiologist working at the working at Intra-Dermal Anti-Rabies Clinic and Research Centre of Deen Dayal Upadhyay Hospital, Himachal Pradesh.


Reduction of cost

“It’s a revolutionary treatment that drastically reduces the dose of medicine,” said Bharti, according to The News Minute.

He added, “so is the cost of treatment that would drastically cut to just Rs 350 ($5.50) from the existing Rs 35,000 ($545) per patient”.


How does the vaccine work?

Previously, the vaccine with rabies immunoglobulins for a monkey or dog bite would be administered intradermally, one each on the wound and the muscle. The rabies immunoglobulin was calculated according to patient’s body weight, which was a costly proposition.

Now, the dosage still needs to be calculated according to the patient’s body weight but now only one vaccine needs to be administered directly to the wound.

The omission of rabies immunoglobulins administration intramuscularly would drastically reduce the cost of treatment from Rs 35,000 to Rs 350 per patient and will have a huge impact globally by sparing the overall cost, medicine and thus saving lives, Bharti explained.

“We started practical research on administering rabies immunoglobulins in wound only in 2014 amidst an acute shortage of this lifesaving medicine, with technical support of WHO Collaborating Centre on Rabies Research in NIMHANS,” he said.

“We administered the anti-rabies vaccine intradermally as earlier along with local rabies immunoglobulins infiltration into wounds. We found that even the lab confirmed rabid dog bite victims survived without any adverse impact,” Bharti said.


Money spent on Rabies vaccine now

At present over $1.6 billion are annually spent on the rabies post-exposure prophylaxis across the globe, which is likely to come down to few million dollars as over 90 percent of this cost is attributed to rabies immunoglobulins to be given as per the earlier WHO protocol that came in 1992, as reported by The News Minute.

There are 59,000 reported deaths due to rabies in the world and India accounts for 20,000 of them. It is because of the cost and the unavailability of the medicine that deaths occur.


Contributors

Written by : Poorbita Bagchi

Edited by :

Share your thoughts..

Related Stories

‘Fugitive Economic Offenders Bill’ Approved By Cabinet For Defaulters Who Escape From Country

Everything You Need To Know About Kejriwal’s Doorstep Delivery Scheme Recently Approved By L-G

DR Ramana Rao

Meet The Doctor Who Treats 700-1200 Patients Free Of Cost Every Sunday

Fortis Hospital Billed Scheduled Drug At 4.4 Times And Consumable At More Than 18 Times The Procurement Price

First Ever Cancer Gene Therapy For Leukemia Gets Approved By US Regulators

Maharashtra Board Approved History Video Showing Arunachal Pradesh & Aksai Chin As Disputed Territories

Latest on The Logical Indian

My Story

My Story: “It Was In College I Experienced People Treating Me Differently For The First Time”

Exclusive

South Delhi: Resident Welfare Association Claim That Public Parks Are Being Used For Political Activities

News

Ajit Doval’s Son Files Defamation Complaint Against Jairam Ramesh & Caravan Magazine

News

India’s Inequality: Country’s Richest 1% Grew Their Wealth By 39% In 2018, Says Oxfam Report

Get Inspired

All Women Assam Rifles Contingent To Script History, Will March Past Rajpath This Republic Day For The First Time

News

Mukesh Ambani Announces Plan To Take On Online Retail Giants Amazon And Flipkart

x

Stories that deserve attention, delivered to your inbox!

Handpicked, newsworthy stories which deserve the attention of a rational generation.